T1	Participants 65 108	patients receiving intravenous antibiotics:
T2	Participants 389 453	specific for a patient group receiving prolonged courses of i.v.
T3	Participants 454 466	antibiotics.
T4	Participants 625 682	Patients with cystic fibrosis receiving intermittent i.v.
T5	Participants 683 694	antibiotics
T6	Participants 1611 1646	patients requiring longer term i.v.
T7	Participants 1647 1654	access.
